Literature DB >> 15016861

Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.

Elena N Peletskaya1, Alex A Kogon, Steven Tuske, Edward Arnold, Stephen H Hughes.   

Abstract

Site-directed photoaffinity cross-linking experiments were performed by using human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) mutants with unique cysteine residues at several positions (i.e., positions 65, 67, 70, and 74) in the fingers subdomain of the p66 subunit. Since neither the introduction of the unique cysteine residues into the fingers nor the modification of the SH groups of these residues with photoaffinity cross-linking reagents caused a significant decrease in the enzymatic activities of RT, we were able to use this system to measure distances between specific positions in the fingers domain of RT and double-stranded DNA. HIV-1 RT is quite flexible. There are conformational changes associated with binding of the normal substrates and nonnucleoside RT inhibitors (NNRTIs). Cross-linking was used to monitor intramolecular movements associated with binding of an NNRTI either in the presence or in the absence of an incoming deoxynucleoside triphosphate (dNTP). Binding an incoming dNTP at the polymerase active site decreased the efficiency of cross-linking but caused only modest changes in the preferred positions of cross-linking. This finding suggests that the fingers of p66 are closer to an extended template in the "open" configuration of the enzyme with the fingers away from the active site than in the closed configuration with the fingers in direct contact with the incoming dNTP. NNRTI binding caused increased cross-linking in experiments with diazirine reagents (especially with a diazirine reagent with a longer linker) and a moderate shift in the preferred sites of interaction with the template. Cross-linking occurred closer to the polymerase active site for RTs modified at positions 70 and 74. The effects of NNRTI binding were more pronounced in the absence of a bound dNTP; pretreatment of HIV-1 RT with an NNRTI reduced the effect of dNTP binding. These observations can be explained if the binding of NNRTI causes a decrease in the flexibility in the fingers subdomain of RT-NNRTI complex and a decrease in the distance from the fingers to the template extension.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016861      PMCID: PMC371094          DOI: 10.1128/jvi.78.7.3387-3397.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

Review 1.  NNRTIs-a new class of drugs for HIV.

Authors:  S M Drake
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

2.  Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding.

Authors:  J Ren; C Nichols; L E Bird; T Fujiwara; H Sugimoto; D I Stuart; D K Stammers
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

Review 3.  Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom.

Authors:  O S Pedersen; E B Pedersen
Journal:  Antivir Chem Chemother       Date:  1999-11

4.  Monte Carlo calculations on HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor 8-Cl TIBO: contribution of the L100I and Y181C variants to protein stability and biological activity.

Authors:  M B Smith; M L Lamb; J Tirado-Rives; W L Jorgensen; C J Michejda; S K Ruby; R H Smith
Journal:  Protein Eng       Date:  2000-06

5.  Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1.

Authors:  P L Boyer; A L Ferris; S H Hughes
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

6.  Crystals of a ternary complex of human immunodeficiency virus type 1 reverse transcriptase with a monoclonal antibody Fab fragment and double-stranded DNA diffract x-rays to 3.5-A resolution.

Authors:  A Jacobo-Molina; A D Clark; R L Williams; R G Nanni; P Clark; A L Ferris; S H Hughes; E Arnold
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

7.  Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.

Authors:  S Benn; R Rutledge; T Folks; J Gold; L Baker; J McCormick; P Feorino; P Piot; T Quinn; M Martin
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

8.  Trapping of a catalytic HIV reverse transcriptase*template:primer complex through a disulfide bond.

Authors:  H Huang; S C Harrison; G L Verdine
Journal:  Chem Biol       Date:  2000-05

9.  Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA.

Authors:  S G Sarafianos; K Das; C Tantillo; A D Clark; J Ding; J M Whitcomb; P L Boyer; S H Hughes; E Arnold
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

10.  Cross-linking of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase to template-primer.

Authors:  E N Peletskaya; P L Boyer; A A Kogon; P Clark; H Kroth; J M Sayer; D M Jerina; S H Hughes
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

View more
  15 in total

1.  Minimalist model for force-dependent DNA replication.

Authors:  Eva X Nong; Stephen J DeVience; Dudley Herschbach
Journal:  Biophys J       Date:  2012-02-21       Impact factor: 4.033

2.  Domain structure and three-dimensional model of a group II intron-encoded reverse transcriptase.

Authors:  Forrest J H Blocker; Georg Mohr; Lori H Conlan; Li Qi; Marlene Belfort; Alan M Lambowitz
Journal:  RNA       Date:  2004-12-01       Impact factor: 4.942

Review 3.  Studying DNA-protein interactions with single-molecule Förster resonance energy transfer.

Authors:  Shazia Farooq; Carel Fijen; Johannes Hohlbein
Journal:  Protoplasma       Date:  2013-12-28       Impact factor: 3.356

4.  A Novel Leu92 Mutant of HIV-1 Reverse Transcriptase with a Selective Deficiency in Strand Transfer Causes a Loss of Viral Replication.

Authors:  Eytan Herzig; Nickolay Voronin; Nataly Kucherenko; Amnon Hizi
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

5.  A toolkit and benchmark study for FRET-restrained high-precision structural modeling.

Authors:  Stanislav Kalinin; Thomas Peulen; Simon Sindbert; Paul J Rothwell; Sylvia Berger; Tobias Restle; Roger S Goody; Holger Gohlke; Claus A M Seidel
Journal:  Nat Methods       Date:  2012-11-11       Impact factor: 28.547

6.  Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV-1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine.

Authors:  Nicole Bertoletti; Albert H Chan; Raymond F Schinazi; Y Whitney Yin; Karen S Anderson
Journal:  Protein Sci       Date:  2019-08-06       Impact factor: 6.725

7.  Solution structural dynamics of HIV-1 reverse transcriptase heterodimer.

Authors:  James M Seckler; Kathryn J Howard; Mary D Barkley; Patrick L Wintrode
Journal:  Biochemistry       Date:  2009-08-18       Impact factor: 3.162

8.  Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription.

Authors:  Kylie Warren; David Warrilow; Luke Meredith; David Harrich
Journal:  Viruses       Date:  2009-11-10       Impact factor: 5.048

9.  Localization of ASV integrase-DNA contacts by site-directed crosslinking and their structural analysis.

Authors:  Elena Peletskaya; Mark Andrake; Alla Gustchina; George Merkel; Jerry Alexandratos; Dongwen Zhou; Ravi S Bojja; Tadashi Satoh; Mikhail Potapov; Alex Kogon; Viktor Potapov; Alexander Wlodawer; Anna Marie Skalka
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

Review 10.  Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?

Authors:  Athanasios-Dimitrios Bakasis; Theodoros Androutsakos
Journal:  Cells       Date:  2021-05-15       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.